IRIS
MICIACCIA, MORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 379
EU - Europa 257
AS - Asia 143
SA - Sud America 17
OC - Oceania 5
Totale 801
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 363
IT - Italia 162
CN - Cina 57
SG - Singapore 56
SE - Svezia 43
CA - Canada 16
GB - Regno Unito 11
JP - Giappone 11
CZ - Repubblica Ceca 9
DE - Germania 9
IN - India 9
BE - Belgio 7
CL - Cile 7
AU - Australia 5
BR - Brasile 4
HU - Ungheria 4
PE - Perù 4
KR - Corea 3
CH - Svizzera 2
ID - Indonesia 2
IL - Israele 2
IR - Iran 2
NL - Olanda 2
RU - Federazione Russa 2
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
EE - Estonia 1
FR - Francia 1
IE - Irlanda 1
PK - Pakistan 1
UA - Ucraina 1
VE - Venezuela 1
Totale 801
Salva come PNG Salva come JPEG
Città #
Sannicandro di Bari 57
Chandler 48
Nyköping 39
Fairfield 37
Singapore 37
Ashburn 35
Bari 33
Cambridge 17
Woodbridge 16
Houston 13
Seattle 13
Beijing 12
Toronto 10
Wilmington 10
Bitonto 9
Brno 8
Munich 8
New York 8
Tokyo 8
Brussels 7
Santiago 7
Ann Arbor 6
Lawrence 6
Milan 6
Dearborn 5
Roxbury 5
Shanghai 5
Adelaide 4
Arequipa 4
Boardman 4
Des Moines 4
Kornye 4
Lincoln 4
Rome 4
Valenzano 4
Valparaiso 4
Wallsend 4
Florence 3
Inglewood 3
Massafra 3
Nanjing 3
Racale 3
Stanford 3
Alexandria 2
Altamura 2
Bedford 2
Chur 2
Coimbatore 2
Grottaglie 2
Hemel Hempstead 2
Irving 2
Malang 2
Maple 2
Minneapolis 2
New Delhi 2
Nishiōizumi 2
Port Clinton 2
Reggio Emilia 2
San Diego 2
San Francisco 2
Santa Clara 2
Santa Marinella 2
Saskatoon 2
Taranto 2
Tel Aviv 2
Triggiano 2
Virginia Beach 2
Wuhan 2
Wuxi 2
Adelfia 1
Altoona 1
Ardabil 1
Bloomington 1
Brisbane 1
Brooklyn 1
Caracas 1
Changsha 1
Chengdu 1
Criciúma 1
Fort Worth 1
Groningen 1
Harbin 1
Hebei 1
Hefei 1
Heze 1
Hounslow 1
Iguatu 1
Indore 1
Jiaxing 1
Jinhua 1
Kampong Loyang 1
Kimstad 1
Kostyantynivka 1
Lanús 1
Livermore 1
London 1
Los Angeles 1
Monmouth Junction 1
Multan 1
Musashino 1
Totale 606
Salva come PNG Salva come JPEG
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 150
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 111
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 91
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 57
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 49
Three-dimensional structure of human cyclooxygenase (hCOX)-1 45
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 41
Ovine COX-1 Isoenzyme Bio-production 41
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 26
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 25
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 20
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 19
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 18
Structure-activity relationships of piperazine-2-one derivatives as novel human ClpP activators 18
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 17
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 16
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 15
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 15
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 13
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 13
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 12
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 12
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 11
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 11
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior 10
Inside circular economy challenges: “green” application to valorise olive mill wastewater 9
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 9
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges 7
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug. 6
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery 6
Design and synthesis of new [4,5-b] and [4,5-c] imidazopyridines as potential fluorophores/inhibitors for Human Cyclooxygenase-1. 3
Potassium channels and TRPV1 modulators on SU-DIPG-36 and SU-DIPG-50 cells: in vitro effects and channel currents characterization 3
The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 cells 2
Totale 901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 7 7 7 7 9 17 9 4
2020/202187 7 4 0 8 10 8 0 8 16 15 7 4
2021/202275 10 6 1 2 2 5 2 14 3 8 9 13
2022/2023152 8 19 17 6 18 21 4 27 19 4 6 3
2023/2024295 4 14 14 24 26 18 16 7 95 35 16 26
2024/2025191 41 14 40 35 61 0 0 0 0 0 0 0
Totale 901